RxDoctor Payments Data

Jennifer Vandivier

Medical · West Des Moines, IANPI 1225081482

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 91.9% of the total across 253 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 27 manufacturers, the largest accounting for just 23.2% — the pattern of someone who eats at a lot of different presentations. Among medical clinicians in IA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$4,950in general payments, 2019–2025

Across 253 payments — averaging $19.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • UCB, Inc.$658
  • Johnson & Johnson$481
  • Novartis$387
  • Sanofi$351
  • Sanofi-aventis U.S. LLC$292
  • plus $2K from 21 others

What the payments were for

  • Food & beverage$4,55192%
  • Education$4008%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,950 in reported general payments places this provider in the 90th percentile of 141 medical providers in Iowa.

See all medical providers in Iowa

Medicare billing

Part B allowed, 2024
$168,012
Medicare patients
776
Services billed
3,569

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Clobetasol Propionate60$3,139
Fluocinonide46$2,236
Ketoconazole93$1,680
Betamethasone Dipropionate32$1,400
Fluorouracil17$1,312
Triamcinolone Acetonide100$1,202
Metronidazole25$862
Doxycycline Hyclate32$350
ValacyclovirValacyclovir Hcl18$327
Hydrocortisone66$280
Doxycycline Monohydrate20$236
Econazole Nitrate15$217
Cephalexin20$214
Mupirocin24$138
Silver Sulfadiazine11$48

Paid to pharmacies, not to this prescriber.

Other medical in West Des Moines

See the full list for Iowa

Where these figures come from

Is this you, or does something look wrong? →